Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT03203330
PHASE3

A Study to Determine the Safety and Efficacy of TG-C in Subjects With Kellgren and Lawrence Grade 2 or 3 OA of the Knee

Sponsor: Kolon TissueGene, Inc.

View on ClinicalTrials.gov

Summary

A randomized, double-blind, placebo-controlled, multi-center, phase 3 study to determine the safety and efficacy of TG-C in subjects with Kellgren and Lawrence Grade 2 or 3 Osteoarthritis of the Knee, Osteoarthritis Research Society International (OARSI) medial joint space narrowing (JSN) Grade 1 or 2 of the knee joint. TG-C is to be administered by a single intra-articular injection to the damaged joint area via ultrasound guidance. Patients will be followed for 24 months for safety and efficacy.

Official title: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase 3 Study to Determine the Efficacy of TG-C in Subjects With Kellgren and Lawrence Grade (KLG) 2 or 3 Osteoarthritis of the Knee

Key Details

Gender

All

Age Range

40 Years - Any

Study Type

INTERVENTIONAL

Enrollment

535

Start Date

2018-10-30

Completion Date

2026-07-10

Last Updated

2025-12-30

Healthy Volunteers

No

Interventions

BIOLOGICAL

TG-C

2 mL injection of non-transduced human chondrocytes and irradiated transduced human GP2-293 cells expressing TGF-B1.

BIOLOGICAL

Placebo Control

2 mL normal saline injection

Locations (44)

Jeffrey Davis

Birmingham, Alabama, United States

Bradly Goodman

Birmingham, Alabama, United States

Saima Chohan

Phoenix, Arizona, United States

Nebojsa Skrepnik

Tucson, Arizona, United States

Diraj Karnani

Apple Valley, California, United States

Dan La

Covina, California, United States

Scott Hacker

La Mesa, California, United States

Eric Grigsby

Napa, California, United States

Arthur Mabaquiao

San Diego, California, United States

Timothy Davis

Santa Monica, California, United States

Tien-I Su

Whittier, California, United States

Mehul Desai

Washington D.C., District of Columbia, United States

David Billmeier

Daytona Beach, Florida, United States

Mercedes Ponce De Leon

Miami, Florida, United States

Aurelio Torres-Consuegra

Miami, Florida, United States

Edgar Gonzalez

Miami, Florida, United States

Cathy Barnes

New Port Richey, Florida, United States

Howard Chipman

Oldsmar, Florida, United States

Richard Linn

Sunrise, Florida, United States

Anand Patel

Winter Park, Florida, United States

Sandeep Vaid

Newnan, Georgia, United States

Dennis Levinson

Chicago, Illinois, United States

Manish Jain

Chicago, Illinois, United States

Hythem Shadid

Oak Brook, Illinois, United States

Adil Fatakia

Marrero, Louisiana, United States

James Nace

Baltimore, Maryland, United States

Melvin Churchill

Lincoln, Nebraska, United States

Jason Oh

New York, New York, United States

Brett Gilbert

Durham, North Carolina, United States

Jeremy Hoff

Wilmington, North Carolina, United States

Yogesh Mittal

Tulsa, Oklahoma, United States

Alan Kivitz

Duncansville, Pennsylvania, United States

Edward Tavel

Columbia, South Carolina, United States

Eric Loudermilk

Greenville, South Carolina, United States

Harvey Bowles

Nashville, Tennessee, United States

Daneshvari Solanki

Bellaire, Texas, United States

Amr Morsy

Dallas, Texas, United States

Haresh Boghara

DeSoto, Texas, United States

Aldo Maspons

El Paso, Texas, United States

Subodh Bhuchar

Houston, Texas, United States

Brian MacGillivray

San Antonio, Texas, United States

John Hemmersmeier

South Ogden, Utah, United States

Kristen Holtz

Charlottesville, Virginia, United States

Mark Hermann

Danville, Virginia, United States